As we’re sure you’ve been aware, October has been our personalised medicine focus month. Find out what we loved this month and take a look at what’s to come for the rest of 2012. I suppose I should start by saying…. “Happy Halloween”!! While there were no ghosts or goblins on pharmaphorum…
Kevin Hrusovsky of PerkinElmer Inc. discusses the role of next generation sequencing in personalized medicine in the concluding part of his interview. Previously in this three-part interview Kevin shared with us the most recent exciting advances in the understanding of molecular interactions…
In the second part of this three-part interview, Kevin Hrusovsky discusses next generation sequencing. In part one of this three-part interview, Kevin Hrusovsky highlighted some exciting recent advances in the understanding of molecular…
In the first of this three-part interview series, Kevin Hrusovsky shares the most exciting recent advances in understanding molecular interactions of a disease. Recently we have seen some very exciting breakthrough in our understanding of molecular interactions of diseases, notably in breast cancer…
